Leonor Adriana Barile Fabris

Learn More
BACKGROUND The pharmacologic management of rheumatoid arthritis has progressed substantially over the past years. It is therefore desirable that existing information be periodically updated. There are several published international guidelines for the treatment of rheumatoid arthritis that hardly adapt to the Mexican health system because of its limited(More)
Biotechnological drugs (BTDs) are complex molecules whose manufacturing process precludes the ability to identically reproduce the structure of the original product, and therefore there cannot be an absolute equivalence between the original (innovative) medication and its biosimilar counterpart. BTDs have been proven useful in the treatment of several(More)
BACKGROUND Pulmonary hemorrhage (PH) occurs in 2-5% of SLE patients, and is associated with a high mortality rate (79-90%). Diagnostic criteria for this complication include: 1) Pulmonary infiltrates, with at least ¾ of lung tissue involved in a chest x ray, 2) Acute respiratory failure, 3) A decrease of 3g/dL or more in hemoglobin levels. PH might lead to(More)
Leonor Adriana Barile Fabris asume el cargo de editora de Reuatología Clínica a partir de Noviembre del 20011 y por un período e dos años, sucediendo en el cargo al Dr. Jordi Gratacós Masmitjà. La Dra. Barile cursó sus estudios profesionales en la Escuela exicana de Medicina de la Universidad la Salle de 1977 a 1982, y e Reumatología en el Hospital de(More)
  • 1